X4 Pharmaceuticals, Inc
Biotechnology company · Boston, Massachusetts, United States · Nasdaq: XFOR
X4 Pharmaceuticals, Inc is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2010. Its shares trade on Nasdaq under the ticker XFOR. It has reported private securities offerings to the US SEC, most recently $85 million sold in a notice filed in 2025.
X4 Pharmaceuticals at a glance
What does X4 Pharmaceuticals do?
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $85 million sold (2025).
Frequently asked questions about X4 Pharmaceuticals
Where is X4 Pharmaceuticals headquartered?
X4 Pharmaceuticals, Inc is headquartered in Boston, Massachusetts, United States.
What does X4 Pharmaceuticals do?
X4 Pharmaceuticals, Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is X4 Pharmaceuticals a public company?
Yes. X4 Pharmaceuticals, Inc trades on Nasdaq under the ticker XFOR.
When was X4 Pharmaceuticals founded?
The earliest incorporation on record for X4 Pharmaceuticals, Inc is in 2010, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences